451
Views
13
CrossRef citations to date
0
Altmetric
Original Articles: Clinical

Successful peripheral blood stem cell mobilization with a cost-efficient single fixed-dose plerixafor schedule in poor mobilizers

, , , , , , , & show all
Pages 1849-1858 | Received 07 Jun 2016, Accepted 07 Dec 2016, Published online: 13 Jan 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Christine Greil, Gabriele Ihorst, Chrissoula Kiote-Schmidt, Steffi Hildenbeutel, Katja Kühbach, Roland Bosse, Justus Duyster, Monika Engelhardt & Ralph Wäsch. (2018) Stem cell mobilization in poor mobilizers with multiple myeloma or lymphoma before and after introduction of plerixafor: a single-center comparative analysis using a cost-efficient single fixed-dose schedule. Leukemia & Lymphoma 59:7, pages 1722-1725.
Read now

Articles from other publishers (12)

Xiaolei Wei & Yongqiang Wei. (2023) Stem cell mobilization in multiple myeloma: challenges, strategies, and current developments. Annals of Hematology 102:5, pages 995-1009.
Crossref
Zoe van de Wyngaert, Florent Malard, Cyrille Hulin, Denis Caillot, Clara Mariette, Thierry Facon, Cyrille Touzeau, Aurore Perrot, Philippe Moreau, Benjamin Hebraud, Tarik Kanouni, Farhad Heshmati, Delphine Lebon, Mohamad Mohty & Christian Chabannon. (2023) Non-interventional Study Evaluating the Mobilization of Stem Cells by Plerixafor Before Salvage Autologous Stem Cell Transplant in Relapsed Multiple Myeloma (IFM-2015-03). Clinical Hematology International 5:1, pages 38-42.
Crossref
Katharina Kriegsmann, Max Bittrich, Sandra Sauer, Carola Tietze-Stolley, Kamran Movassaghi, Matthias Grube, Vladan Vucinic, Daniela Wehler, Andreas Burchert, Martin Schmidt-Hieber, Andreas Rank, Heinz A. Dürk, Bernd Metzner, Christoph Kimmich, Marcus Hentrich, Christian Kunz, Frank Hartmann, Cyrus Khandanpour, Maike de Wit, Udo Holtick, Michael Kiehl, Andrea Stoltefuß, Alexander Kiani, Ralph Naumann, Christian W. Scholz, Hans-Joachim Tischler, Martin Görner, Franziska Brand, Martin Ehmer & Nicolaus Kröger. (2023) Mobilization and Hematopoietic Stem Cell Collection in Poor Mobilizing Patients with Lymphoma: Final Results of the German OPTIMOB Study. Transfusion Medicine and Hemotherapy 50:5, pages 403-416.
Crossref
Shinsuke Iida, Tadao Ishida, Katsuhisa Horimoto, Hirotaka Kazama, Hyunchung Kim, Bruce Crawford & Takanori Teshima. (2020) Medical database analysis of japanese multiple myeloma patients with planned stem cell transplantation (MEDALIST) – a focus on healthcare resource utilization and cost. International Journal of Hematology 113:2, pages 271-278.
Crossref
Zoé Van de Wyngaert, Virginie Nerich, Guillemette Fouquet, Marie-Lorraine Chrétien, Denis Caillot, Nabih Azar, Laurent Garderet, Pascal Lenain, Margaret Macro, Jean-Henri Bourhis, Ramdane Belhocine, Arnaud Jaccard, Lionel Karlin, Arthur Bobin, Niels Moya, Thomas Systchenko, Cecile Gruchet, Christine Giraud, Stéphanie Guidez, Claire Darras, Isabelle Princet, Cyrille Touzeau, Philippe Moreau, Cyrille Hulin, Erik Deconinck, Samuel Limat & Xavier Leleu. (2020) Cost and efficacy of peripheral stem cell mobilization strategies in multiple myeloma. Bone Marrow Transplantation 55:12, pages 2254-2260.
Crossref
Rocío Parody, Isabel Sánchez-Ortega, Christelle Ferrá, Ramon Guardia, Carme Talarn, Maite Encuentra, Eduard Fort, David López, Mireia Morgades, Eva Alonso, Sandra Ortega, Josep Sarrá, David Gallardo, Josep M. Ribera & Anna Sureda. (2020) Mobilization of Hematopoietic Stem Cells into Peripheral Blood for Autologous Transplantation Seems Less Efficacious in Poor Mobilizers with the Use of a Biosimilar of Filgrastim and Plerixafor: A Retrospective Comparative Analysis. Oncology and Therapy 8:2, pages 311-324.
Crossref
Cesar Homero Gutiérrez‐Aguirre, Dalila Marisol Alvarado‐Navarro, Alain Palomares‐Leal, Gerardo Mejía‐Jaramillo, Rosario Salazar‐Riojas, Andrés Gómez‐De León, Perla Rocío Colunga‐Pedraza, Guillermo Sotomayor‐Duque, José Carlos Jaime‐Pérez, Olga Graciela Cantú‐Rodríguez, Luz Carmen Tarín‐Arzaga, Juan Antonio Flores‐Jiménez & David Gómez‐Almaguer. (2019) Reduced‐dose plerixafor as a mobilization strategy in autologous hematopoietic cell transplantation: a proof of concept study. Transfusion 59:12, pages 3721-3726.
Crossref
Francisco López-Castaño, Pablo Manresa, Vanesa Díaz, Eva Arranz, Javier López, María Pérez, Olga Alda & Luis Hernández. (2019) Comparison and cost analysis of three protocols for mobilization and apheresis of haematopoietic progenitor cells. Journal of Clinical Apheresis 34:4, pages 461-467.
Crossref
M. Engelhardt, G. Graziani, R. Javorniczky, J. Neubauer, M. Köhler, G. W. Herget & R. Wäsch. (2018) Therapie des rezidivierten und refraktären multiplen MyelomsTreatment of relapsed and refractory multiple myeloma. Der Onkologe 24:8, pages 613-624.
Crossref
Emre Tekgündüz, Mutlu Arat, Hakan Göker, Hakan Özdoğu, Leylagül Kaynar, Seçkin Çağırgan, Mehmet Ali Erkurt, Filiz Vural, İlhami Kiki, Fevzi Altuntaş & Fatih Demirkan. (2017) Autologous hematopoietic progenitor cell mobilization and collection in adult patients presenting with multiple myeloma and lymphoma: A position-statement from the Turkish Society of Apheresis (TSA). Transfusion and Apheresis Science 56:6, pages 845-849.
Crossref
Emre Tekgündüz, Fatih Demirkan, Filiz Vural, Hakan Göker, Hakan Özdoğu, İlhami Kiki, İsmet Aydoğdu, Leylagül Kaynar, Mehmet Ali Erkurt, Seçkin Çağırgan, Sevgi Beşışık, Simten Dağdaş, Ebru Koca, Gürhan Kadıköylü, Eren Gündüz, Mehmet Yılmaz, Hüseyin Beköz, Ali Uğur Ural, Abdülkadir Baştürk, Mutlu Arat, Murat Albayrak, Erman Öztürk, Alev Akyol, Ali Zahit Bolaman, Oral Nevruz, Hasan Atilla Özkan, Gökhan Özgür & Fevzi Altuntaş. (2017) Current practice of autologous hematopoietic progenitor cell mobilization in adult patients with multiple myeloma and lymphoma: The results of a survey from Turkish hematology research and education group (ThREG). Transfusion and Apheresis Science 56:6, pages 804-808.
Crossref
Johannes M. Waldschmidt, Anna Simon, Dagmar Wider, Stefan J. Müller, Marie Follo, Gabriele Ihorst, Sarah Decker, Joschka Lorenz, Manik Chatterjee, Abdel K. Azab, Justus Duyster, Ralph Wäsch & Monika Engelhardt. (2017) CXCL12 and CXCR7 are relevant targets to reverse cell adhesion-mediated drug resistance in multiple myeloma. British Journal of Haematology 179:1, pages 36-49.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.